AsiaMedic to acquire LuyeEllium Healthcare for S$42.2 million
ASIAMEDIC has entered into a conditional sale and purchase agreement with the shareholders of LuyeEllium Healthcare to acquire the company for S$42.2 million.
LuyeEllium provides hospital management services to hospitals in South Korea and China.
The consideration will be fulfilled via the issuance of 527.1 million new shares, at the issue price of eight Singapore cents per share.
Upon completion of the proposed acquisition, it will be a wholly owned subsidiary of the AsiaMedic.
AsiaMedic will be appointing an independent valuer to prepare a valuation report on LuyeEllium.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance